Page last updated: 2024-09-05

lu 135252 and thromboxane b2

lu 135252 has been researched along with thromboxane b2 in 1 studies

Compound Research Comparison

Studies
(lu 135252)
Trials
(lu 135252)
Recent Studies (post-2010)
(lu 135252)
Studies
(thromboxane b2)
Trials
(thromboxane b2)
Recent Studies (post-2010) (thromboxane b2)
19613147,483715485

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Janzen, R; Koch, T; Münter, K; Neuhof, H; Schmeck, J1

Other Studies

1 other study(ies) available for lu 135252 and thromboxane b2

ArticleYear
Endothelin-1 and thromboxane A2 increase pulmonary vascular resistance in granulocyte-mediated lung injury.
    Critical care medicine, 1998, Volume: 26, Issue:11

    Topics: 6-Ketoprostaglandin F1 alpha; Analysis of Variance; Animals; Cyclooxygenase Inhibitors; Diclofenac; Disease Models, Animal; Endothelin Receptor Antagonists; Endothelin-1; Female; Granulocytes; In Vitro Techniques; Male; N-Formylmethionine Leucyl-Phenylalanine; Perfusion; Phenylpropionates; Prospective Studies; Pulmonary Artery; Pyrimidines; Rabbits; Random Allocation; Respiratory Distress Syndrome; Thromboxane A2; Thromboxane B2; Vascular Resistance

1998